These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3315819)

  • 1. Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis.
    Okita K; Matsuda S; Hanta T; Yasunaga M; Sanuki K; Takemoto T
    Gastroenterol Jpn; 1987 Oct; 22(5):607-13. PubMed ID: 3315819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin and glucagon on serum amino acid concentrations in liver disease.
    Watanabe A; Higashi T; Hayashi S; Obata T; Sakata T; Takei N; Shiota T; Nagashima H
    Acta Med Okayama; 1982 Dec; 36(6):441-6. PubMed ID: 6760674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the effects of insulin/glucagon infusions, parenteral amino acids and high dose corticosteroids on survival in a rabbit model of acute fulminant hepatitis.
    Minuk GY; Sherman TA; Shaffer EA; Kelly SK
    Hepatology; 1986; 6(1):73-8. PubMed ID: 3510952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival rate in children with fulminant hepatitis improved by a combination of twice daily plasmapheresis and intensive conservative therapy.
    Shin K; Nagai Y; Hirano C; Kataoka N; Ono I; Yamamura E; Moriyama C; Horigome Y; Ehara T; Kamoda T
    J Pediatr Gastroenterol Nutr; 1989 Aug; 9(2):163-6. PubMed ID: 2509666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nursing care of the patient with fulminant hepatitis undergoing glucagon-insulin therapy].
    Nakano M; Ota M; Tominaga C; Ono J; Matsuda N
    Kango Gijutsu; 1984 Sep; 30(12):1605-12. PubMed ID: 6384594
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial.
    Bird G; Lau JY; Koskinas J; Wicks C; Williams R
    Hepatology; 1991 Dec; 14(6):1097-101. PubMed ID: 1959860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients.
    Baker AL; Jaspan JB; Haines NW; Hatfield GE; Krager PS; Schneider JF
    Gastroenterology; 1981 Jun; 80(6):1410-4. PubMed ID: 7014349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.
    Kato Y; Nakata K; Omagari K; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Yano M; Eguchi K
    Intern Med; 2001 Jan; 40(1):5-8. PubMed ID: 11201371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial.
    Trinchet JC; Balkau B; Poupon RE; Heintzmann F; Callard P; Gotheil C; Grange JD; Vetter D; Pauwels A; Labadie H
    Hepatology; 1992 Jan; 15(1):76-81. PubMed ID: 1727803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of glucagon and insulin in therapy of fulminant hepatic failure.
    Okita K; Matsuda S; Hata K; Morimoto T; Sasaki M; Fukumoto Y; Kodama T; Takemoto T
    Gastroenterol Jpn; 1979 Oct; 14(5):453-7. PubMed ID: 520769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged intrahepatic cholestasis in acute-onset, severe autoimmune hepatitis.
    Motoo Y; Sawabu N; Watanabe H; Okai T; Nakanuma Y
    J Gastroenterol; 1997 Jun; 32(3):410-3. PubMed ID: 9213259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure.
    Harrison PM; Hughes RD; Forbes A; Portmann B; Alexander GJ; Williams R
    J Hepatol; 1990 May; 10(3):332-6. PubMed ID: 2195108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis.
    Fehér J; Cornides A; Romány A; Kárteszi M; Szalay L; Gógl A; Picazo J
    J Hepatol; 1987 Oct; 5(2):224-31. PubMed ID: 3320181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of fulminant hepatic failure with insulin and glucagon. A randomized, controlled trial.
    Woolf GM; Redeker AG
    Dig Dis Sci; 1991 Jan; 36(1):92-6. PubMed ID: 1702048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of insulin and glucagon in fulminant murine viral hepatitis.
    Farivar M; Wands JR; Isselbacher KJ; Bucher NL
    Lancet; 1976 Mar; 1(7961):696-7. PubMed ID: 73670
    [No Abstract]   [Full Text] [Related]  

  • 16. A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis.
    Oka H; Fujiwara K; Okita K; Ishii H; Sakuma A
    Gastroenterol Jpn; 1989 Jun; 24(3):332-6. PubMed ID: 2663609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of exchange transfusion in fulminant hepatitis.
    Rivera RA
    Med Ann Dist Columbia; 1972 May; 41(5):277-80. PubMed ID: 4502787
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal alpha cell function in diabetics response to insulin.
    Unger RH; Madison LL; Muller WA
    Diabetes; 1972 May; 21(5):301-7. PubMed ID: 24683634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prediction, diagnosis and therapy of fulminant hepatitis].
    Muto Y; Murakami N; Sugihara J
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1012-7. PubMed ID: 2230480
    [No Abstract]   [Full Text] [Related]  

  • 20. [Imbalance of amino acid metabolism in fulminant hepatitis and its management].
    Kato A; Suzuki K; Sato S
    Nihon Rinsho; 1992 Jul; 50(7):1599-603. PubMed ID: 1404890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.